Stephens Consulting’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1K | Buy |
25
+10
| +67% | +$4.06K | ﹤0.01% | 321 |
|
|
2025
Q1 | $7.46K | Sell |
15
-34
| -69% | -$16.9K | ﹤0.01% | 356 |
|
|
2024
Q4 | $25.5K | Hold |
49
| – | – | 0.01% | 247 |
|
|
2024
Q3 | $30.3K | Sell |
49
-5
| -9% | -$3.09K | 0.01% | 225 |
|
|
2024
Q2 | $29.9K | Buy |
54
+29
| +116% | +$16K | 0.01% | 228 |
|
|
2024
Q1 | $14.5K | Sell |
25
-24
| -49% | -$14K | ﹤0.01% | 282 |
|
|
2023
Q4 | $26K | Hold |
49
| – | – | 0.01% | 229 |
|
|
2023
Q3 | $24.8K | Hold |
49
| – | – | 0.01% | 229 |
|
|
2023
Q2 | $25.6K | Hold |
49
| – | – | 0.01% | 226 |
|
|
2023
Q1 | $28.2K | Hold |
49
| – | – | 0.02% | 220 |
|
|
2022
Q4 | $27K | Hold |
49
| – | – | 0.02% | 214 |
|
|
2022
Q3 | $24.9K | Hold |
49
| – | – | 0.02% | 235 |
|
|
2022
Q2 | $26.6K | Hold |
49
| – | – | 0.02% | 222 |
|
|
2022
Q1 | $28.9K | Buy |
49
+25
| +104% | +$14.8K | 0.02% | 231 |
|
|
2021
Q4 | $16K | Buy |
+24
| New | +$16K | 0.01% | 326 |
|